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Human milk banks: a need for further evidence and guidance
Human milk is the biological norm for nutrition in 
infants, with a mother’s own milk recognised as the 
ideal nutritional source for optimal infant health. When 
a mother’s own milk is unavailable, WHO1 and UNICEF 
recommend donor human milk as the best alternative 
for babies with low birthweights. Growing recognition of 
the benefits of donor human milk has led to increasing 
global interest in creating and sustaining human milk 
banks to fulfil the need for donor human milk.
Human milk banks have now been established in 
over 60 countries globally, with a small but increasing 
number of milk banks operating in low-income and 
middle-income countries.2 This growth has led to calls 
for equitable access to human milk for vulnerable 
infants, such as low birthweight babies with necrotising 
enterocolitis.3 Despite recommendations for donor 
human milk and the global expansion of human 
milk banks, little authoritative guidance exists on 
the implementation, operation, and regulation of 
human milk banks. The importance of safe operational 
guidelines and a coordinating body to collate and 
communicate data have been highlighted by the milk-
banking community and emphasised by the current 
COVID-19 pandemic.4
In response to this need, the Institute of Biomedical 
Ethics and History of Medicine of the University of 
Zurich organised an international expert meeting on 
the need for global guidance for human milk banking, 
also sponsored by WHO.5 Although the meeting 
confirmed the demand for formal guidance among the 
milk banking community, particularly in low-income 
and middle-income countries, it also revealed several 
fundamental issues that need to be addressed.
Human milk is classified differently worldwide, leading 
to variation in the legal frameworks governing its use 
and operating procedures. Most commonly, human milk 
is categorised as a food or nutritional therapy.6 Unlike 
other food substances, donor human milk is a biological 
material derived from the human body and processed 
with the intention of clinical application. As such, WHO 
considers it a medical product of human origin.7 A 
consensus on the nature of human milk as a regulated 
substance needs to be agreed upon before deliberation 
on a unified set of procedures on safe handling and 
precautions for appropriate use to begin.
The evidence is clear that donor human milk is 
beneficial to the health of vulnerable infants, particularly 
for preventing necrotising enterocolitis and improving 
feeding tolerance.8 Little evidence exists on the effect 
of donor human milk on other health issues, including 
sepsis. The value of donor human milk for healthy 
term infants is not documented. More evidence is also 
needed to understand the effect of the different types of 
handling, processing, or pasteurisation procedures, and 
fortifications of donor human milk after processing, all 
of which determine the properties of the resultant milk. 
This knowledge is necessary to inform guidelines on 
optimum processing of donor human milk for specific 
health needs of infants.
There are a multitude of ethical issues around 
human milk banking, beginning from procurement 
and extending through to processing, storage, and 
allocation. Judging how these concerns play out in 
different cultural and socioeconomic contexts, and 
identifying the most appropriate policy response, is 
currently limited by a shortage of studies.
The motivations behind donating human milk 
remain under-researched. Motivations include 
expressions of altruism, finding use for excess 
expressed milk, access to breastfeeding support 
through participation in human milk donation 
programmes,9 and coping with grief after the loss of 
an infant.10 Although these donations can sometimes 
be reimbursed in recognition of the substantial time 
and effort required to donate human milk, the ability 
to donate regularly over a period of months could be 
perceived as a financial opportunity for donors from 
low-income groups to support their families. The issue 
of reimbursement is complicated by the operations 
of for-profit companies selling donor human milk, 
violating the principles of managing medical products 
of human origin.7
Additionally, providing human milk for monetary 
compensation could harm donors from low 
socioeconomic groups who are likely to have poor 
baseline health and nutrition. The additional lactogenesis 
puts them at risk for maternal depletion, leading to 
negative energy balance and nutrient deficiences. Milk 
could also be diverted from an infant to meet incentivised 
demands for donor human milk.
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As a medical product of human origin, donor human 
milk is subject to the principles of universal coverage 
with equitable access and allocation systems based on 
clinical criteria and ethical norms.7 In practice, covering 
the cost of donor human milk for recipients can present 
a challenge, especially in countries without universal 
health coverage. Donor human milk is not always 
covered by insurance, and families might have to pay for 
access themselves.
The ready availability of donor human milk from 
human milk banks could lead to the use of donor human 
milk as a convenience product at the expense of efforts 
to support breastfeeding and the provision of a mother’s 
own milk. The priority in clinical settings should always 
be to support mothers in providing their own milk to 
their babies. It is important to ensure that resources for 
supporting breastfeeding are not diverted towards the 
establishment or running of human milk banks.
The ability to provide human milk to all infants who 
need it contributes to a health system’s ability to achieve 
health and development commitments relating to 
human rights, UN Sustainable Development Goals, and 
targets for maternal, infant, and young child nutrition. 
At the same time, important technical and ethical issues 
need to be urgently clarified to minimise the potential of 
harm.
Building on the important gaps that have been 
identified, a succinct research agenda will need to be 
defined that allows us to efficiently produce the evidence 
that is required to develop robust global guidance on 
the processes relevant to human milk banking, and the 
appropriate use of donor human milk.
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